Michael Joseph Ezra Sternberg
Fondateur chez Equinox Pharma Ltd.
Profil
Michael Joseph Ezra Sternberg is the founder of Equinox Pharma Ltd., which was founded in 2002.
He holds the title of Non-Executive Director at Equinox Pharma Ltd.
from 2010 to the present.
Currently, Dr. Sternberg is the Chairman-Structural Bioinformatics at Imperial College London.
In the past, he worked as a Director at IP2IPO Innovations Ltd.
He was also a Member at the University of London from 1983 to 1988 and the Head-Biomolecular Modelling Laboratory at Cancer Research UK from 1988 to 2001.
Postes actifs de Michael Joseph Ezra Sternberg
| Sociétés | Poste | Début |
|---|---|---|
Equinox Pharma Ltd.
 Equinox Pharma Ltd. Pharmaceuticals: MajorHealth Technology Equinox Pharma Ltd. provides informatics products and services used in the discovery and development of drugs. Its services include input screening data, rule-based model, predict a ranked list of active compounds and data source services. The company was founded on November 20, 2002 by Stephen Howard Muggleton, Michael Joseph Ezra Sternberg and Paul Simon Freemont and is headquartered in London, the United Kingdom. | Fondateur | 08/01/2010 |
| Imperial College London | Corporate Officer/Principal | - |
Anciens postes connus de Michael Joseph Ezra Sternberg
| Sociétés | Poste | Fin |
|---|---|---|
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/01/2001 |
| University of London | Corporate Officer/Principal | 01/01/1988 |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Equinox Pharma Ltd.
Equinox Pharma Ltd. Pharmaceuticals: MajorHealth Technology Equinox Pharma Ltd. provides informatics products and services used in the discovery and development of drugs. Its services include input screening data, rule-based model, predict a ranked list of active compounds and data source services. The company was founded on November 20, 2002 by Stephen Howard Muggleton, Michael Joseph Ezra Sternberg and Paul Simon Freemont and is headquartered in London, the United Kingdom. | Health Technology |
IP2IPO Innovations Ltd.
IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Commercial Services |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Commercial Services |
